News & Updates
Filter by Specialty:
Pandemic contributes to poor mental, oral health
Oral health has been mildly compromised during the coronavirus disease 2019 (COVID-19) pandemic, particularly among people who have been infected and those suffering from depression, anxiety, and psychological stress, a recent study reported.
Pandemic contributes to poor mental, oral health
22 Mar 2022
Novel EGFR-TKI drug shows favourable antitumour activity in NSCLC
Treatment with the novel EGFR tyrosine kinase inhibitors (EGFR-TKI) abivertinib at 300 mg twice a day appears to be effective in patients with EGFR T790M-positive nonsmall cell lung cancer (NSCLC), while having manageable side effects, according to the results of a phase II trial.
Novel EGFR-TKI drug shows favourable antitumour activity in NSCLC
22 Mar 2022
Fulvestrant–sapanisertib combo shows modest benefit in advanced, metastatic breast cancer
Treatment with the combination of fulvestrant plus sapanisertib yields a numerical increase in progression-free survival in patients with ER-positive, HER2-negative advanced or metastatic breast cancer as compared with the use of fulvestrant alone, according to the results of a phase II trial. However, the combination is associated with increased toxicity.
Fulvestrant–sapanisertib combo shows modest benefit in advanced, metastatic breast cancer
22 Mar 2022
IL-6 may mediate psychosomatic syndromes in HF patients
Levels of the proinflammatory cytokine interleukin (IL)-6 seem to be associated with psychosomatic symptoms in patients with heart failure (HF), reports a recent study.
IL-6 may mediate psychosomatic syndromes in HF patients
21 Mar 2022
5 factors predict death in moderate/severe mitral regurgitation
Patients with moderate or severe mitral regurgitation who have been admitted for heart failure exacerbation or has an elevated right atrial pressure, renal dysfunction, anaemia, or lacks a mitral valve intervention suffer a greater risk of all-cause mortality, reveals a study.
5 factors predict death in moderate/severe mitral regurgitation
21 Mar 2022
Age, medication use affect initial response to SARS-CoV-2 vaccines among IBD patients
Most patients with inflammatory bowel disease (IBD) build an initial immune response to SARS-CoV-2 vaccination, but older patients, those treated with antitumour necrosis factor (anti-TNF) and an immunomodulator, and those on corticosteroids may require an additional vaccine dose to achieve better immunity against COVID-19, according to a study.
Age, medication use affect initial response to SARS-CoV-2 vaccines among IBD patients
21 Mar 2022
Oral antibiotics not inferior to IV-only therapy in blood, bone infections
Use of oral antibiotics in the treatment of osteomyelitis, bacteraemia, and infective endocarditis results in shorter hospital stay, has a better safety profile, and appears to be similarly effective when compared to intravenous (IV)-only therapy, a recent study has shown.